Careers Together, we are redefining patient outcomes COUR / kôr / abbreviated from cour·age: mental or moral strength to venture, persevere, and withstand ...

Reprogramming the immune system. Restoring lives.At COUR, we develop targeted therapies that incite calm within the immune system and help restore the healt ...

Pipeline Introducing the next generation of disease-modifying therapies Our first-in-class, disease-modifying, targeted therapies are designed to safely reg ...

Platform Autoimmune disease is a global health crisis. We are working to change that. In the US alone, 23 million people live with autoimmune disease, and a ...

Oct 1, 2025 · News See our press releases and media coverage to read the most up-to-date news about our work. Please contact [email protected] with all media inq ...

Stan Russell joined COUR in 2024 as VP, Quality, where he oversees the quality control and quality assurance functions. Stan is a 35+ year life sciences veteran with experience in engineering, …

Dannielle Appelhans is the President and Chief Executive Officer (CEO) of COUR, bringing extensive operational and leadership experience in the biotechnology industry and a dedication to providing …

Lonnie D. Shea, PhD, is a world-leading biomaterial scientist and coinventor of the COUR nanoparticle technology platform. Dr. Shea currently serves as the Steven A. Goldstein Collegiate Professor in the …

Mandatory Binding Arbitration of Disputes. By agreeing to these Terms, you agree that any dispute, claim, or controversy arising out of or relating to these Terms or the breach, termination, …

Andrea Chen joined COUR in 2025 as Head of Program Management, overseeing the strategic planning, coordination, and execution of development activities across all programs. With over 15 …